Related Experiment Video

Updated: Feb 8, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.9K

Necrotizing pneumonia caused by refractory Mycoplasma pneumonia pneumonia in children

Xia Wang1, Li-Jia Zhong1, Zhi-Min Chen1

  • 1Children's Hospital, Zhejiang University School of Medicine, No. 3333 Binsheng Road, Hangzhou, 310052, China.

World Journal of Pediatrics : WJP
|June 28, 2018
PubMed
Abstract

Insights

Necrotizing pneumonia caused by refractory Mycoplasma pneumoniae pneumonia is severe but reversible. Prompt and appropriate clinical management leads to good outcomes for affected children.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Pulmonology

Background:

  • Refractory Mycoplasma pneumoniae pneumonia (RMPP) can lead to severe necrotizing pneumonia (NP).
  • Understanding the clinical profile of NP in RMPP is crucial for effective treatment.

Purpose of the Study:

  • To investigate the clinical features of necrotizing pneumonia (NP) in children with refractory Mycoplasma pneumoniae pneumonia (RMPP).

Main Methods:

  • Retrospective observational study of 25 pediatric patients with NP caused by RMPP.
  • Analysis of clinical manifestations, laboratory data, imaging, hospital course, and outcomes.

Main Results:

  • Patients presented with prolonged fever and elevated inflammatory markers (LDH, CRP, IL-6, IL-10, interferon-gamma).
  • High incidence of pleural effusion, lobar atelectasis, and pulmonary consolidation observed.
  • Mean duration to necrotic lesion discovery was 21 days; most patients received corticosteroids and prolonged antibiotics.

Conclusions:

  • Necrotizing pneumonia due to RMPP is a severe but self-limiting condition.
  • Appropriate management, including antibiotics and supportive care, leads to reversible outcomes.
  • Children with NP caused by RMPP can achieve good recovery without surgical intervention.
Keywords:
ChildrenMycoplasma pneumoniaeNecrotizing pneumoniaRefractory

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

15.2K
Experimental Model to Evaluate Resolution of Pneumonia09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.9K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
911
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.0K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
828
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
893
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
312